Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial [Phase 2]
Phase 2 trial evaluating Folate Receptor Alpha Dendritic Cells (FRαDCs) vs placebo for stage III/IV ovarian, fallopian tube, or primary peri…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) [Phase 3]
Phase 3 trial (OVA-302) evaluating Gleolan (5-ALA) for fluorescence-guided visualization in newly diagnosed or recurrent ovarian cancer is c…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: FaCT Trial (Facilitated Cascade Testing Trial) [NA]
Clinical trial update for the FaCT Trial (Facilitated Cascade Testing Trial) sponsored by Weill Medical College of Cornell University; curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical study evaluating SHR-A1811 in combination with chemotherapy for platinum-sensitive recurrent ovarian cancer is currentl…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]
This clinical trial update describes a Phase 2 long-term treatment extension study of niraparib for participants who completed a prior GSK/T…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer [NA]
A clinical trial evaluation of the Tiaoshen Anti-Cancer Regimen for treating psycho-neurological symptom clusters in ovarian cancer; current…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]
Phase 3 trial MATAO is evaluating maintenance therapy with an aromatase inhibitor in epithelial ovarian cancers; the study is currently recr…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) [Phase 1, Phase 2]
This clinical trial update reports Eli Lilly's KRAS G12C inhibitor LY3537982 is being studied in Phase 1/2 trials across multiple KRAS G12C-…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating pembrolizumab in combination with the DPX-Survivac vaccine and cyclophosphamide for advanced ova…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of ERX-315 in patients with metastatic breast, ovarian, endometrial, liver, or pancreatic cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with carboplatin for recurrent ovarian cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: AOH1996 for the Treatment of Refractory Solid Tumors [Phase 1]
AOH1996 is being studied in a Phase 1 trial for patients with refractory solid tumors, including osteosarcoma and several other sarcomas and…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: HRD Tests for Ovarian cancER [Phase 2]
Phase 2 clinical trial update evaluating homologous recombination deficiency (HRD) testing in ovarian cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients [Phase 4]
Phase 4 update on first-line treatment with olaparib in combination with bevacizumab for HRD-positive ovarian cancer patients.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital is sponsoring a study to develop a uterine lavage test for detecting ovarian cancer, and the trial is current…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal [NA]
An update on a trial sponsored by Institut de Cancérologie de Lorraine evaluating liquid biopsy in newly diagnosed high-grade adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer is currently …
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Identifying Genetic Targets in Gynecological Tumors
An ongoing clinical trial sponsored by Azienda USL Reggio Emilia - IRCCS is recruiting to identify genetic targets in gynecologic tumors, fo…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial comparing niraparib alone to niraparib plus bevacizumab in advanced ovarian, fallopian tube, and peritoneal cancers is curre…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Genetically Modified T Cells Against Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating genetically modified T cells for ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Clinical Validation of Sophia Genetics Assay
Clinical trial update reporting validation of the Sophia Genetics assay, with NOT_YET_RECRUITING status across ovarian cancer, breast cancer…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tub…